LabPro Microbiology Informatics Suite
Beckman Coulter Diagnostics
Shipped Product
Multi-product suite
Portfolio Scale
Exceeded
Revenue Target
Protected
DoD Revenue
3 major deals
Competitive Wins
2 months early
Delivery Timeline
3 products
Suite Components
HealthcareDiagnosticsFDA ComplianceCybersecurityLaboratory InformaticsAntimicrobial StewardshipProduct Suite8 min read
01
The Challenge
Inherited a mature 3-product software suite serving clinical microbiology laboratories, facing urgent challenges:
Critical Issues:
- DoD cybersecurity compliance gaps threatening significant revenue
- Aging platform architecture limiting future growth
- Fragmented vendor relationships delaying automation integration
- Evolving customer needs requiring next-generation platform vision
The Challenge: Balance sustaining current customer base while modernizing platform under FDA regulatory constraints.
03
My Approach
Took ownership of established LabPro software suite portfolio and drove critical enhancements:
1. DoD Cybersecurity Compliance:
- Delivered FDA-compliant cybersecurity features under aggressive timeline
- Protected DoD revenue at risk through rapid roadmap pivot
2. Automation Integration:
- Launched third-party automation integration through external vendor partnership
- Expanded product compatibility with lab automation systems
3. Platform Modernization:
- Defined VOC-driven roadmap for next-generation platform
- Addressed technical debt while supporting future growth
4. Portfolio Sustaining:
- LabPro Information Manager with AlertEX rules engine for antimicrobial stewardship
- LabPro Connect multi-user access eliminating workflow bottlenecks
- LabPro-MBT MALDI-TOF integration for rapid identification
04
Impact & Results
Delivered critical business outcomes:
Revenue Protection:
- Protected significant DoD revenue by delivering cybersecurity solutions 2 months ahead of deadline
- Exceeded portfolio revenue targets while driving competitive wins
Product Enhancements:
- Launched automation integration expanding product compatibility
- Achieved 3 major competitive wins
Platform Evolution:
- Defined VOC-driven roadmap for next-generation platform
- Enhanced antimicrobial stewardship efforts through integrated AlertEX system
- Epidemiology reporting capabilities used by infection control teams nationwide
05🔬
The Evidence: How We Validated This
Dataset & Baseline
Inherited mature product suite portfolio with established customer base. Identified at-risk DoD revenue from emerging cybersecurity compliance gap. Historical competitive win rate indicated opportunity for growth. Existing suite architecture: 3 integrated products serving clinical labs, but workflow challenges remained (technicians spending 20+ minutes/day navigating between disconnected workstations).
Method & Approach
Why sustain existing architecture vs rebuild: Customer base stability and FDA validation timeline prohibited greenfield rebuild. Chose targeted enhancements vs comprehensive platform overhaul. Phased cybersecurity delivery over comprehensive solution to meet FDA timeline while protecting DoD revenue. Partnered with external vendor for automation integration vs in-house development (faster market entry, leveraged existing LabPro Connect architecture). Maintained existing AlertEX rules engine with CLSI/EUCAST standards while adding cybersecurity layers.
How We Measured Success
Revenue target exceeded as measured via annual financial reports. Protected DoD revenue validated through maintained customer base during cybersecurity transition without customer churn. Competitive wins tracked via CRM data. Delivery timeline tracked via project milestones (2 months early vs DoD compliance deadline). Customer testimonials from clinical lab technologists validated that enhancements improved workflows without disrupting existing operations.
Limitations & Trade-offs
Inherited technical debt limited innovation speed (worked within existing architecture constraints vs ideal greenfield design). Aggressive cybersecurity timeline required scope reduction (core DoD compliance vs comprehensive security overhaul). Resource concentration on DoD crisis meant delayed other customer-requested features. External vendor partnership for automation vs full control (faster but created new dependency). Phased next-gen platform approach vs forcing immediate migration (protected customer relationships but extended modernization timeline).
Frameworks & Methodologies
Agile/ScrumVoice of Customer (VOC)Danaher Business SystemFDA Risk ManagementCLSI/EUCAST StandardsAntimicrobial Stewardship
Cross-Functional Collaboration
Global Cross-Functional Leadership:
- Led teams across R&D, regulatory affairs, quality assurance, commercial, and DoD compliance
- Managed stakeholder alignment across Americas, EMEA, APAC markets
- Partnered with external vendor for automation integration and next-gen platform
Key Product Decisions
Critical Product Decisions:
- Prioritized cybersecurity compliance over feature expansion to protect DoD revenue
- Chose phased delivery over comprehensive solution to meet critical deadline
- Balanced FDA requirements with customer requests and competitive positioning
Constraints Navigated
Major Challenges:
- Strict FDA regulatory timelines and DoD cybersecurity certification
- Global regulatory variations across markets
- Legacy system integration challenges
- Resource constraints during critical delivery periods
Competitive Positioning
Market Differentiation:
- Superior cybersecurity compliance - First to market with DoD-compliant features in microbiology informatics
- Seamless LIS/EMR integration - Better interoperability than competitors
- Comprehensive AlertEX rules engine - Industry-leading antimicrobial stewardship capabilities
- LabPro Connect advantage - Eliminated workflow bottlenecks competitors couldn't solve without expensive infrastructure upgrades
Stakeholder Feedback
“"LabPro AlertEX is fantastic. Keeping up with ongoing changes to what is reportable for antibiotic rules is difficult. My laboratory staff and I rely on the LabPro AlertEX system to do this for us. I don't know how we would work without it." - Jennifer Blakeney, M.T. (ASCP), Lead Microbiology/Immunology Technologist, Beebe Medical Center”
“"The learning curve was absolutely miniscule because it is such a user-friendly product. It saves us so much time and frustration and we're much more efficient." - Kim Pannke, M.T. (ASCP), John Muir Medical Center”
“"No more shuffling through paper. Able to view WalkAway Monitor at bench and give anyone who calls real-time results." - Karen Hitterman, MT (ASCP), Loyola University Laboratory”
Reflection & Learnings
Key Learnings from Sustaining Engineering:
Inheriting a mature platform taught me unique challenges: balancing customer requests with technical debt, managing legacy code constraints while innovating, and earning trust of existing customer base during critical transitions.
Urgent Requirements Lesson: DoD revenue risk showed importance of rapid roadmap pivots when you don't control original architecture.
What I'd Do Differently: Invest earlier in understanding technical debt and vendor dependencies before committing to aggressive timelines.
Career Impact: Prepared me to lead platform modernization at Danaher and navigate complexities of sustaining large-scale enterprise software.
My Role
Global Product Manager, Informatics
Domain: Diagnostics & Laboratory Informatics
Technologies & Tools
Laboratory Information SystemsFDA 510(k) SoftwareDoD Cybersecurity ComplianceHealthcare Interoperability (HL7/FHIR)MALDI-TOF IntegrationRemote DiagnosticsMulti-User Network Architecture